Drugs / ALVAC-CEA-B7.1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00027833 | Dec 2001 → ? | colorectal cancer | Herbert Irving Comprehensive Cancer Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALVAC-CEA/B7.1 | “Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.” PMID 18676757 ↗ Aug 2008 |
| Route | Subcutaneous | “ALVAC-CEA-B7.1 vaccine subcutaneously (SC) once weekly for 3 weeks” NCT00027833 ↗ |